The aim of this study was to evaluate the validity and reliability of homeostasis model assessment-insulin resistance (HOMA-IR) index, its reciprocal (1/HOMA-IR), quantitative insulin sensitivity check index (QUICKI) and McAuley's index in hypertensive diabetic patients. In 78 patients with hypertension and type II diabetes glucose, insulin and triglyceride levels were determined after a 12-h fast to calculate these indices, and insulin sensitivity (IS) was measured with the hyperinsulinemic euglycemic clamp technique. Two weeks later, subjects had again their glucose, insulin and triglycerides measured. Simple and multiple linear regression analysis were applied to assess the validity of these indices compared to clamp IS and coefficients of variation between the two visits were estimated to assess their reproducibility. HOMA-IR index was strongly and inversely correlated with the basic IS clamp index, the Mvalue (r ¼ À0.572, Po0.001), M-value normalized with subjects' body weight or fat-free mass and every other clamp-derived index. 1/HOMA-IR and QUICKI indices were positively correlated with the M-value (r ¼ 0.342, Po0.05 and r ¼ 0.456, Po0.01, respectively) and the rest clamp indices. McAuley's index generally presented less strong correlations (r ¼ 0.317, Po0.05 with M-value). In multivariate analysis, HOMA-IR was the best fit of clampderived IS. Coefficients of variation between the two visits were 23.5% for HOMA-IR, 19.2% for 1/HOMA-IR, 7.8% for QUICKI and 15.1% for McAuley's index. In conclusion, HOMA-IR, 1/HOMA-IR and QUICKI are valid estimates of clamp-derived IS in patients with hypertension and type II diabetes, whereas the validity of McAuley's index needs further evaluation. QUICKI displayed better reproducibility than the other indices.
Introduction
The term 'metabolic' or 'insulin-resistance' syndrome refers to a clustering in the same individual of disorders that represent risk factors for cardiovascular disease (CVD), such as impaired glucose tolerance (IGT) or type II diabetes, hypertension, dyslipidaemia and obesity. 1 Insulin resistance (IR) was originally proposed to be the central disorder of the syndrome, causally related with the other disturbances. 2 In addition, both IR and compensatory hyperinsulinemia have been independently associated in longitudinal studies with increased risk for CVD. 3, 4 In certain individuals, IR can precede the development of type II diabetes for many years, even decades. 5, 6 During this long course compensatory hyperinsulinemia can have harmful consequences on many tissues not presenting IR and, through various mechanisms, contribute to the development of other components of the syndrome, that is hypertension or hypertriglyceridemia. 7, 8 Thus, a proportion of subjects with the metabolic syndrome can exhibit hypertension long before the development of overt type II diabetes.
Several methods have been proposed for assessment of IR, or its reciprocal variable, insulin sensitivity (IS), in humans. Among them the hyperinsulinemic euglycemic clamp technique, described by DeFronzo et al. 9 in 1979, represents currently the 'gold standard'. 10 However, due to its many technical requirements, the clamp technique, as well as several other methods for IS measurement, is difficult to apply in everyday clinical practice or large-scale epidemiologic studies. This is why during the past 20 years numerous simple indices have been developed for IS measurement. Some of these indices derive from an oral-glucose tolerance test, whereas others are based only on fasting glucose and insulin values, 1 and this simplicity in obtaining the latter surrogates was the obvious reason for their wider use.
Among these indices, the most well-known is perhaps the homeostasis model assessment-insulin resistance (HOMA-IR) index, 11 whereas the reciprocal of HOMA-IR, as well as a more recently proposed index, the quantitative insulin sensitivity check index (QUICKI), 12 are increasingly used. The validity of these estimates in relation to the clamp technique has been examined in several studies, in a wide variety of populations. [13] [14] [15] [16] [17] [18] [19] [20] However, data on their validity in hypertensive populations are generally limited. Recently, McAuley et al. 21 proposed another index, which uses fasting insulin and triglyceride values, to be a strong predictor of clamp-derived IS, but this index was not adequately further investigated. In addition, data on the reproducibility of these surrogate indexes are quite limited 11, 13, 19, 22 compared to the data on validity. Therefore, the aim of the present study was to determine the comparative validity and the reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's index in a population consisting of patients that have initially developed hypertension and subsequently type II diabetes.
Methods

Subjects
Among patients attending the hypertension or diabetes outpatient clinic of the 1st Department of Medicine, AHEPA Hospital, Thessaloniki, Greece, we selected those with both hypertension and type II diabetes that had diagnosis of hypertension before the diagnosis of diabetes. We excluded patients receiving insulin treatment, having glycated hemoglobin (HbA 1c ) 410%, history of secondary hypertension, serum creatinine levels 42 mg/dl, history of myocardial infarction or unstable angina within the past 6 months, heart failure NYHA class III-IV, malignancy or any other condition with poor prognosis. From this population we randomly selected 100 individuals, using a computer-generated list. Of these, six were not possible to be contacted and eight refused to participate. The remaining 86 subjects volunteered for the study, providing informed consent after information. Three of those subjects did not show up at the scheduled days for the evaluation and five of them did not undergo the clamp due to difficulties in achieving stable intravenous access. Therefore, the final study group included 78 Caucasian patients (36 men and 42 women) with complete data set, which were included in the analysis.
Study protocol
Participants were admitted to the Clinical Research Laboratory of our Department at 0700 after a 12-h overnight fast and without having received their morning hypoglycemic or antihypertensive medication. Blood samples were drawn to determine the levels of fasting plasma glucose, insulin and triglycerides and HbA 1c . Fasting glucose and insulin values were used to estimate HOMA-IR, 1/HOMA-IR and QUICKI indices and insulin and triglycerides to estimate the McAuley's index, as described below. Subjects had also measured their body weight and height to calculate body mass index (BMI). The body composition of each participant was then analysed by bioelectrical impedance analysis with the use of the Bodystat1500 device (Bodystat Ltd, Douglas, Isle of Man, British Isles) to estimate the fat-free mass. Bioelectrical impedance analysis has been shown to be a simple, valid and reliable method to evaluate body composition. 23, 24 After these procedures, subjects had their IS determined with the clamp technique.
Two weeks after the first visit, participants returned at the Department, again after a 12-h fast and without having received morning medications to give blood samples for the determination of fasting plasma glucose, insulin and triglyceride levels (visit 2). From these values, all surrogate indices were again calculated to evaluate their reproducibility between different time points. All subjects were strictly advised to keep their diet habits and physical activity unchanged during these 2 weeks to avoid major changes in background IR.
Assessments
Hyperinsulinemic euglycemic clamp. The hyperinsulinemic euglycemic clamp was performed as described previously. 9, 10 In brief, two intravenous infusion lines were placed, one into an antecubital vein for the infusion of insulin and glucose and the other into a hand or wrist vein by retrograde cannulation for frequent blood sampling. After a 10-min priming infusion, insulin infusion was held constant at 0.6 nmol * m À2 * min À1 for the rest 110 min. Blood glucose concentration was determined every 5 min and it was clamped at the euglycemic level (5 mmol/l) by infusion of variable amounts of a 20% dextrose solution. The total body glucose disposal rate (M-value), the basic clamp-derived IS index, was the average value of the glucose infusion rate during the final 40 min of the 120-min study (steady-state). As different studies have used various sub-indices derived from the clamp, the M-value was normalized with body weight (M bw ) and fat-free mass (M ffm ) for reasons of comparison. 10 The mean of the three plasma insulin measurements obtained at 80, 100 and 120 min of the study represented steadystate insulin and was used to standardize M-values, thus forming the respective M/I indices. Metabolic clearance rate (MCR) of plasma glucose, the last clamp-derived index, was obtained by dividing the respective M-values by the mean steady-state plasma glucose concentrations, and was again further normalized with body weight and fat-free mass.
9,10
Estimation of surrogate indices. HOMA-IR index was calculated according to the formula: HOMA-IR ¼ fasting glucose in mmol/l * fasting insulin in mU/ml/22.5.
11 The reciprocal of HOMA-IR was calculated from the type: 1/HOMA-IR ¼ 1/[HOMA-IR]. QUICKI was estimated according to the formula by Katz et al. 12 : QUICKI ¼ 1/[log(fasting insulin in mU/ml) þ log(fasting glucose in mg/dl)]. Accordingly, McAuley's index was calculated from the formula: McAuley's index ¼ exp[2.63À0.28 ln (fasting insulin in mU/ml)À0.31 ln (fasting triglycerides in mmol/l)]. 21 Biochemical analyses. Plasma glucose and triglycerides were measured with standard laboratory methods in Roche/Hitachi 912 automatic analyser (Roche Diagnostics, Basel, Switzerland). Plasma insulin was determined by radioimmunoassay (DiaSorin, Saluggia, Italy). HbA 1c was measured with high-performance liquid chromatography (Menarini Diagnostics, Florence, Italy). Glucose measurements during the clamp were performed with HemoCue B-glucose analyser (Hemocue AB, Ä ngelholm, Sweden). This analyser was found accurate in comparison to standard laboratory methods. 25 In previous works of our group, HemoCue rendered a correlation coefficient of r ¼ 0.98 and a within-run variation o1.5%.
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Statistical analysis
Statistical analysis was performed using the Statistical Package for Social Sciences 13 software (SPSS PC Inc., Chicago, IL, USA). All data are expressed as mean7s.d. The validity of each surrogate index was assessed with calculation of Pearson's r correlation coefficients between each surrogate index and the indexes of the clamp, for reasons of comparison. Multiple linear regression analysis was performed to determine whether age, sex and BMI influenced the association between each surrogate index and clamp-derived M-value, as well as to explore the estimated best fit for clamp-derived IS. The reproducibility of each index was assessed with the use of the coefficient of variance (CV) between its values at visit 1 and visit 2. The CV was calculated according to the formula: CV ¼ ðs:d:= ffiffiffi 2 p Þ Ã 100=x where s.d. is the standard deviation of the difference between visit 1 and visit 2 and x the pooled mean value for the two visits. We also performed comparisons between the mean values of visit 1 and visit 2 with the use of Student's t-test for paired variables or Wilcoxon's Signed ranks test, depending on normality of distribution, and calculated correlation coefficients between those two occasions. P-value levels o0.05 (two-tailed) were considered statistically significant.
Results
The demographic and clinical characteristics of the total study population, men and women, as well as baseline values of the surrogate indices examined and the various indices derived from the hyperinsulinemic euglycemic clamp are presented in Table 1 .
Correlation analysis demonstrated that HOMA-IR was strongly and inversely correlated with the M (r ¼ À0.572, Po0.001) (Figure 1a ), M/I (r ¼ À0.768, Po0.001) and MCR (r ¼ À0.576, Po0.001) values of the clamp, as well as all the above values normalized with body weight or fat-free mass ( Table 2) . 1/HOMA-IR index, was significantly but positively correlated with M-value (r ¼ 0.342, Po0.05) and the rest clamp-derived indexes ( Figure 1b and Table 2 ). The QUICKI, which also reflects IS, was again positively correlated with M-value (r ¼ 0.456, Po0.01), and with all the rest clamp indexes ( Figure 1c and Table 2 ). Both 1/HOMA-IR and QUICKI exhibited somehow lower correlation coefficients with M, but higher with M/I values than the HOMA-IR index. McAuley's index also demonstrated significant correlations with M (r ¼ 0.317, Po0.05), M/I (r ¼ 0.546, Po0.001) and MCR indexes (r ¼ 0.546, Po0.05). However, it was not significantly correlated with M ffm and MCR ffm indices and its correlation coefficients were lower than all the surrogate indices examined (Figure 1d and Table 2 ).
To explore mutual confounding of the relationships between each surrogated index and clampderived IS from age, sex and BMI, as well as to estimate the best fit for clamp-IS, we performed multiple regression analysis. In all the models developed, the M-value was included as a dependent variable and age, sex and BMI as commonindependent variables. HOMA-IR (model 1), 1/HOMA-IR (model 2), QUICKI (model 3) or McAuley's index (model 4) were each entered as an additional independent variable in respective models. Age did not affect any of the observed associations and further analyses were performed after excluding it. Both the associations between HOMA-IR or QUICKI and the M-value were strengthened after adjustment for sex and BMI, as indicated by the coefficients of determination (Table 3 ). The association between 1/HOMA-IR and the M-value was only affected by sex and adjustment for this factor also strengthened the association, whereas the 
Discussion
This study was designed to determine the validity and the reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's index in a population of patients that have developed hypertension before type II diabetes. The reasons for choosing such patients were that this type of subjects is (a) quite common in clinical practice and (b) closer to the natural course of the metabolic syndrome, thus it could be different in terms of degree of IR from the total hypertensive or the total type II diabetic population, which contains subjects with various levels of IR. 27 Indeed, previous data suggest that individuals with both hypertension and type II diabetes have higher IR than normotensive type II diabetic patients. 28, 29 Our main finding was that HOMA-IR, 1/HOMA-IR and QUICKI indices were strongly and significantly correlated with all the indices derived from clamp technique in this population. These results further prove the validity of these measures to assess IS. McAuley's index presented significant, but less strong, correlations with most of clamp indices. Multivariate analysis revealed that HOMA-IR was the best fit among these indices of clamp-derived IS. However, HOMA-IR, 1/ HOMA-IR and McAuley's indices presented considerably high CVs, a finding questioning their reproducibility.
Since the description of HOMA-IR, 11 several studies reported it to be a valid estimate of clampderived IS in various types of subjects, that is healthy lean individuals, 14, 16, 30, 31 obese subjects, [14] [15] [16] 31 subjects with IGT, 16 type II diabetes, [13] [14] [15] [16] polycystic ovarian syndrome (PCOS), 16 pregnant women, 17 as well as in children and adolescents. 18, 32 However, not all studies confirm the validity of HOMA-IR in certain subject categories, like elderly subjects or women with PCOS. 33, 34 Studies examining the validity of HOMA-IR in patients with hypertension are much less common. Bonora et al.
14 have previously evaluated HOMA-IR in 115 subjects with various degrees of glucose tolerance. In the subgroup of hypertensive patients, HOMA-IR displayed a strong correlation (r ¼ À0.762) with IS represented with the M ffm index. In the only other study so far assessing the accuracy of HOMA-IR in patients with hypertension, Lansang et al. 35 have found HOMA-IR to display again a strong correlation (r ¼ À0.64) with M-value in 27 hypertensives. Our study further supports these findings, as it showed comparable correlation coefficients in a much larger sample of patients.
QUICKI was also found to be a valid surrogate of clamp-derived IS in a similarly broad category of subject types, 12, [16] [17] [18] [19] [20] [30] [31] [32] although there were again some studies with diverse findings. 33, 34 In the only study on accuracy of QUICKI in hypertensives, it was shown to be also highly correlated with IS represented with M bw /I index (r ¼ 0.84) in 27 patients with essential hypertension without diabetes. 36 The validity of 1/HOMA-IR was also evaluated in normal and type II diabetic subjects, 19, 20 but only the previous study examined it in hypertensive patients, showing similar good correlations (r ¼ 0.82). 36 Again, our findings are in total agreement with these results, as we observed almost identical correlations between these indices and M bw /I index.
McAuley et al. 21 originally reported that their index correlated better with clamp-derived IS than a series of surrogate indexes, including HOMA-IR, insulin-to-glucose ratio and Bennett index in the general population. A recent study also showed that McAuley's index had better correlations with clamp-derived IS than both HOMA-IR and QUICKI in 51 stable renal transplant recipients. 37 Our findings do not confirm those results, since McAuley's index was the worse predictor of IS among the surrogate measures examined. It has to be noted, however, that in our population the mean triglyceride level is in the normal range, in contrast to glucose levels, whereas in the study from McAuley et al. 21 subjects are both normoglycemic and normotriglyceridemic. It is not known whether this discrepancy in our population could have affected the performance of this particular index. In any case, further studies seem necessary to assess its true validity.
We have also developed multiple regression analysis models including M-value as dependent variable to determine which of the indices is the strongest predictor of clamp-derived IS. The first model including sex, BMI and HOMA-IR as independent variables predicted 51.4% of the variability in difference in M-value with a formula to estimate the M-value ¼ 0.568À0.746 * sex þ 0.125 * BMIÀ0.305 * HOMA-IR, where sex ¼ 0 for men and 1 for women. 1/HOMA-IR and QUICKI were less strong predictors of clamp-derived IS, something different from previous findings in type II diabetic patients, where both these indices explained about 55% of IS variability. 19 McAuley's index was not an independent predictor of M-value variability in this population.
In regards to reproducibility, although Matthews et al. 11 observed a low precision of the HOMA-IR model (CV of 31%) and suggested that this could limit its use, much less studies examined this aspect 13, 38 compared with the validity of the method. In the original description of QUICKI, Katz et al. 12 supported that their index exerted high reproducibility. However, they assessed reproducibility by comparing the association of each of two separated QUICKI estimations with clamp-derived IS, instead of determining the CV and the association of the two measurements. Subsequent studies showed CVs of 11.7% for HOMA-IR, 13 11.4% for 1/HOMA-IR and 2% for QUICKI 19 in type II diabetic patients, whereas, to our knowledge, no study so far has examined the reproducibility of the McAuley's index. In the present study, the reproducibility of these surrogate indexes is lower than in the above studies, and for HOMA-IR is closer to the estimation of Matthews et al. 11 In a mixed population of healthy lean, obese and type II diabetic individuals, Mather et al. 22 reported a CV of 51% for HOMA and 5% for QUICKI.
A more detailed study also suggested an important intraindividual variation of HOMA-IR, which was significantly higher in patients with type II diabetes than nondiabetic individuals. 38 This could reflect the intraindividual variation of glucose and insulin values, which is also greater in patients with type II diabetes compared to normoglycemic subjects. 39 The critical question is whether this biologic variation of glucose and insulin transferred to surrogate indices limit their ability to give reliable estimates of IS. Studies on the reproducibility of clamp technique are also few, and have shown CVs ranging from 5.8 40 to 15%. 41 If the CV of the clamp is also high, this could reflect the true intraindividual variation of IS, thus the surrogate indexes would just mirror a physiological phenomenon. However, if the reproducibility of the clamp method is around 5%, the surrogate indexes would need to be improved. In any case, the reproducibility of the clamp and the surrogate indices is a field that needs further investigation for stable conclusions to be made.
This study has also some limitations. First, the subjects included were recruited from a population attending Outpatient Clinics of a University Hospital. To what extent these patients differ from similar patients referring to community hospitals, health centres or private physician offices cannot be established. Second, history of hypertension and diabetes was obtained from existing databases of the above Clinics. Although such data are collected systematically, history of diseases is self-reported and, thus, recall bias could potentially exist. Further, it could be argued that it is not known to what extent these data apply to the general hypertensive population, since our subjects had also type II diabetes and vice versa. However, we particularly aimed to examine this question in patients developing hypertension before type II diabetes, as discussed above.
In conclusion, this study suggests that HOMA-IR, 1/HOMA-IR and QUICKI indices are valid estimates of IS in patients with both hypertension and type II diabetes. The McAuley's index is less strongly correlated with clamp-derived IS and should rather not be used instead of the above indices. HOMA-IR seemed the best estimate of clamp-derived IS, but QUICKI displayed a much better reproducibility. On this basis, a judgment should be made on the preferable use of these indices in this type of patients, until future studies elucidate the precision of HOMA-IR and 1/HOMA-IR.
